Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Metastasis Colon Cancer × regorafenib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 29 Carcinoma, Hepatocellular 12 Glioblastoma 5 Colonic Neoplasms 5 Sarcoma, Ewing 3 Rectal Neoplasms 3 Osteosarcoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Leukemia, Myeloid, Acute 2 Gastrointestinal Stromal Tumors 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Chondrosarcoma 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Spinocerebellar Degenerations 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Patient Compliance 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1

Interventions

regorafenib 1 PSMA-BCH 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06071052 2026-03-05

DREAM

First Affiliated Hospital, Sun Yat-Sen University

Phase 2 Completed

Gastrointestinal

Liver Metastasis Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡